Adolphe, M., V. Friese, R. Portet, and J. Cabanes.1987. Étude de l'effet d'un champ magnétique de faible intensité sur la prolifération de plusieurs modèles de cellules en culture. C.R. Soc. Biol. 181:282-286.
2.
Ager, D.D., and J.A. Radul.1992. Effect of 60-Hz magnetic fields on ultraviolet light-induced mutation and mitotic recombination in Saccharomyces cerevisiae . Mutat Res. 283:279-286.
3.
Ames, B.N., and L.S. Gold.1990. Misconceptions on pollution and the causes of cancer. Angew. Chem. Int. Ed. Engl. 29:1197-1208.
4.
Ames, B.N., M.K. Shigenaga, and L.S. Gold.1993. DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis. Environ. Health Perspect. 93:35-44.
5.
Anderson, M.W., S.H. Reynolds, M. You, and R.M. Maronpot.1992. Role of proto-oncogene activation in carcinogenesis. Environ. Health Perspect98:13-24.
6.
Andrews, E.J.1971. Evidence of the nonimmune regression of chemically induced papillomas in mouse skin. J. Natl. Cancer Inst. 47:653-665.
7.
Ashendel, C.L.1985. The phorbol ester receptor: A phospholipid-regulated protein kinase. Biochim. Biophys. Acta. 822:219-242.
8.
Bailleul, B., K. Brown, M. Ramsden, R.J. Akhurst, F. Fee, and A. Balmain.1989. Chemical induction of oncogene mutations and growth factor activity in mouse skin carcinogenesis. Environ. Health Perspect. 81:23-27.
9.
Balcer-Kubiczek, E.K., and G.H. Harrison.1985. Evidence for microwave carcinogenesis in vitro. Carcinogenesis6:859-864.
10.
Balcer-Kubiczek, E.K., and G.H. Harrison.1989. Induction of neoplastic transformation in C3H/10T½ cells by 2.45-GHz microwaves and phorbol ester. Radiat. Res. 117:531-537.
11.
Balcer-Kubiczek, E.K., and G.H. Harrison.1991. Neoplastic transformation of C3H/10T½ cells following exposure to 120-Hz modulated 2.45-GHz microwaves and phorbol ester tumor promoter. Radiat. Res. 126:65-72.
12.
Bauer-Hofmann, R., A. Buchmann, J. Mah, S. Kress, and M. Schwarz.1992. The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice. Carcinogenesis13:477-481.
13.
Baum, A., M. Mevissen, K. Kamino, U. Mohr, and W. Löscher.1995. A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 μT magnetic field exposure. Carcinogenesis16:119-125.
14.
Berenblum, I., and P. Shubik.1947. A new quantitative approach to the study of stages of chemical carcinogenesis in the mouse's skin. Br. J. Cancer1:383.
15.
Bishop, J.M.1985. Viral oncogenes. Cell42:23-38.
16.
Blackburn, E.H.1994. Telomeres: No end in sight. Cell77:621-623.
17.
Boone, C.W., D. Vembu, B.J. White, N. Takeichi, and M. Paranjpe.1979. Karyotypic, antigenic, and kidney-invasive properties of cell lines from fibrosarcomas arising in C3H/10T½ cells implanted subcutaneously attached to plastic plates. Cancer Res. 39:2172-2178.
18.
Boutwell, R.K.1964. Some biological aspects of skin carcinogenesis . Prog. Exp. Tumor. Res. 4:207-250.
19.
Boutwell, R.K.1974. Function and mechanism of promoters of carcinogenesis . CRC Crit. Rev. Toxicol. 2:419-443.
20.
Boyd, J.A., and J.C. Barrett.1990. Genetic and cellular basis of multistep carcinogenesis. Pharmac. Ther. 46:469-486.
21.
Brambilla, G., P. Carlo, R. Finollo, F.A. Bignone, A. Ledda, and E. Cajelli.1983. Viscometric detection of liver DNA fragmentation in rats treated with minimal doses of chemical carcinogens. Cancer Res. 43:202-209.
22.
Bremner, R., C.J. Kemp, and A. Balmain.1994. Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors. Mol. Carcinog. 11:90-97.
23.
Brison, O.1993. Gene amplification and tumor progression. Biochim. Biophys. Acta1155:25-41.
24.
Bronner, C.E., S.M. Baker, P.T. Morrison, G. Warren, L.G. Smith, M.K. Lescoe, M. Kane, C. Earabino, J. Lipford, and A. Lindblom.1994. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer . Nature368:258-261.
25.
Burmer, G.C., and L.A. Loeb.1989. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc. Natl. Acad. Sci. U.S.A. 86:2403-2407.
26.
Burns, F.J., M. Vanderlaan, E. Snyder, and R.E. Albert.1978. Induction and progression kinetics of mouse skin papillomas. In Carcinogenesis, vol.2, mechanism of tumor promotion and cocarcinogenesis, ed. T. J. Slaga, A. Sivak, and R. K. Boutwell, 91-96. New York: Raven Press.
27.
Byus, C.V., S.E. Pieper, and W.R. Adey.1987. The effects of low-energy 60-Hz environmental electromagnetic fields upon the growth-related enzyme ornithine decarboxylase . Carcinogenesis8:1385-1389.
28.
Cadossi, R., F. Bersani, A. Cossarizza, P. Zucchini, G. Emilia, G. Tovelei, and C. Franceschi.1992. Lymphocytes and low-frequency electromagnetic fields. FASEB J. 6:2667-2674.
29.
Campbell, H.A., Y.D. Xu, M.H. Hanigan, and H.C. Pitot.1986. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. Natl. Cancer Inst. 76:751-767.
30.
Candrian, U., M. You, T. Goodrow, R.R. Maronpot, S.H. Reynolds, and M.W. Anderson.1991. Activation of proto-oncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. Cancer Res. 51:1148-1153.
31.
Carter, J.H., H.W. Carter, and J. Meade.1988. Adrenal regulation of mammary tumorigenesis in female Sprague-Dawley rats: Incidence, latency, and yield of mammary tumors . Cancer Res. 48:3801-3807.
32.
Cerny, W.L., K.A. Mangold, and D.G. Scarpelli.1992. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res. 52:4507-4513.
33.
Cha, R.S., W.G. Thilly, and H. Zarbl.1994. N-Nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hrasl gene mutations . Proc. Natl. Acad. Sci. USA91:3749-3753.
34.
Cheng, K.C., and L.A. Loeb.1993. Genomic instability and tumor progression: Mechanistic considerations. Adv. Cancer Res. 60:121-156.
35.
Cleaver, J.E., J.R. Speakman, and J.P.G. Volpe.1995. Nucleotide excision repair: Variations associated with cancer development and speciation. Cancer Surv. 25:125-141.
36.
Cohen, S.M., and L.B. Ellwein.1991. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51:6493-6505.
37.
Cohen, S.M., D.T. Purtilo, and L.B. Ellwein.1991. Pivitol role of increased cell proliferation for the initiation of liver carcinogenesis. Modern Pathol . 4:371-382.
38.
Columbano, A., S. Rajalakshm, and D.S.R. Sarma.1981. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures . Cancer Res. 41:2079-2083.
39.
Corcoran, G.B., L. Fix, D.P. Jones, M.T. Moslen, P. Nicotera, F.A. Oberhammer, and R. Buttyan.1994. Apoptosis: Molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128:169-181.
40.
Corominas, M., S.R. Sloan, J. Leon, H. Kamino, E.W. Newcomb, and A. Pellicer.1991. ras Activation in human tumors and in animal model systems. Environ. Health Perspect. 93:19-25.
41.
Cortés, F., J. Piñero, and T. Ortiz.1993. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases . Mutat. Res. 303:71-76.
42.
Cossarizza, A., D. Monti, F. Bersani, M. Cantini, R. Cadossi, A. Sacchi, and C. Franceschi.1989. Extremely low frequency pulsed electromagnetic fields increase cell proliferation in lymphocytes from young and aged subjects . Biochem. Biophys. Res. Commun. 160:692-698.
43.
Dietrich, D.R., and J.A. Swenberg.1991. The presence of α2u-globulin is necessary for d-Limonene promotion of male rat kidney tumors. Cancer Res. 51:3512-3521.
44.
DiGiovanni, J.1992. Multistage carcinogenesis in mouse skin. Pharmac. Ther. 54:63-128.
45.
Doll, R., and R. Peto.1981. The cause of cacncer. New York: Oxford University Press.
46.
Dominick, M.A., D.G. Robertson, M.R. Bleavins, R.E. Sigler, W.F. Bobrowski, and A.W. Gough.1991. α2u-Globulin nephropathy without nephrocarcinogenesis in male Wistar rats administered 1-(aminomethyl)-cyclohexaneacetic acid. Toxicol. Appl. Pharmacol. 111:375-387.
47.
Donn, A.S., and C.S. Muir.1985. Prostatic cancer: Some epidemiological features. Bull. Cancer (Paris)72:381-390.
Dragan, Y.P., H.A. Campbell, K. Baker, J. Vaughan, M. Mass, and H.C. Pitot.1994. Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats. Carcinogenesis15:2587-2591.
50.
Dulic, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, E. Lees, J.W. Harper, S.J. Elledge, and S.I. Reed.1994. p53-Dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest . Cell76:1013-1023.
51.
Dunham, L.J.1972. Cancer in man at site of prior benign lesion of skin or mucous membrane: A review. Cancer Res. 32:1359-1374.
52.
Elwood, J.M.1984. Initiation and promotion actions of ultraviolet radiation on malignant melanoma. In Models, mechanisms and etiology of tumour promotion, eds. M. Börzsönyi , K. Lapis, N. E. Day , and H. Yamasaki, 421-440. IARC Scientific Publ No. 56, Lyon: International Agency for Research on Cancer.
53.
Fairbairn, D.W., and K.L. O'Neill .1994. The effect of electromagnetic field exposure on the formation of DNA single strand breaks in human cells . Cell. Mol. Biol. 40:561-567.
54.
Fearon, E.R., and B. Vogelstein.1990. A genetic model for colorectal tumorigenesis . Cell61:759-761.
55.
Field, J.K., and D.A. Spandidos.1990. The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis (review) . Anticancer Res. 10:1-22.
56.
Fiorani, M., O. Cantoni, P. Sestili, R. Conti, P. Nicolini, F. Vetrano, and M. Dacha.1992. Electric and/or magnetic field effects on DNA structure and function in cultured human cells. Mutat. Res. 282:25-29.
57.
Fitzsimmons, R.J., J.R. Farley, W.R. Adey, and D.J. Baylink.1989. Frequency dependence of increased cell proliferation, in vitro, in exposures to a low-amplitude, low-frequency electric field: Evidence for dependence on increased mitogen activity released into culture medium. J. Cell Physiol. 139:586-591.
58.
Fornace, A.J., Jr., H. Nagasawa, and J.B. Little.1980. Relationship of DNA repair to chromosome aberrations, sister-chromatid exchanges and survival during liquid-holding recovery in X-irradiated mammalian cells. Mutat. Res. 70:323-336.
59.
Foulds, L.1954. The experimental study of tumor progression: A review . Cancer Res. 14:327-339.
60.
Foulds, L.1965. Multiple etiologic factors in neoplastic development . Cancer Res. 25:1339-1347.
61.
Fuhrmann, E., G. Knedlitschek, and G.K. Wolf1997. Induction of sister chromatid exchanges by modulated low frequency electric fields in fibroblasts from normal donors and from patients with xeroderma pigmentosum and dysplastic nevus syndrome. Eur. J Dermatol. 7:85-88.
62.
Fujiki, H., and M. Suganuma.1993. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: The okadaic acid class of compounds. Adv. Cancer Res. 61:143-194.
63.
Furth, J.1959. A meeting of ways in cancer research: Thoughts on the evolution and nature of neoplasms. Cancer Res. 19:241-256.
64.
Futreal, P.A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L.M. Bennett, A. Hangen-Strano, J. Swenson, and Y. Miki.1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science266:120-122.
Garson, O.M., T.L. McRobert, L.J. Campbell, B.A. Hocking, and I. Gordon.1991. A chromosomal study of workers with long-term exposure to radiofrequency radiation. Med. J. Australia155:289-292.
67.
Geard, C.R., R.S. Osmak, E.J. Hall, H.E. Simon, A.A. Maudsley, and S.K. Hilal.1984. Magnetic resonance and ionizing radiation: A comparative evaluation in vitro of oncogenic and genotoxic potential. Radiology152:199-202.
68.
Glauert, H.P., M. Schwarz, and H.C. Pitot.1986. The phenotypic stability of altered hepatic foci: Effect of the short-term withdrawal of phenobarbital and of the long-term feeding of purified diets after the withdrawal of phenobarbital . Carcinogenesis7:117-121.
69.
Goldsworthy, T.L., M.H. Hanigan, and H.C. Pitot.1986. Models of hepatocarcinogenesis in the rat-contrasts and comparisons. CRC. Crit. Rev. Toxicol. 17:61-89.
70.
Goodman, R., J. Bumann, L.X. Wei, and A. Shirley-Henderson .1992. Exposure of human cells to electromagnetic fields: Effect of time and field strength on transcript levels . Electro-Magnetobiol. 11:19-28.
71.
Graham, C., M.R. Cook, and D.W. Riffle.1996. Human melatonin during continuous magnetic field exposure. Bioelectromagnetics18:166-171.
72.
Grasso, P., and M. Sharratt.1991. Role of persistent, non-genotoxic tissue damage in rodent cancer and relevance to humans. Annu. Rev. Pharmacol. Toxicol. 31:253-287.
73.
Haider, T., S. Knasmueller, M. Kundi, and M. Haider.1994. Clastogenic effects of radiofrequency radiation on chromosomes of Tradescantia. Mutat. Res. 324:65-68.
74.
Hall, A.1994. A biochemical function for ras-at last. Science264:1413-1414.
75.
Hanigan, M.H., and H.C. Pitot.1985. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital. Cancer Res. 45:6063-6070.
76.
Harris, C.C.1991. Chemical and physical carcinogenesis: Advances and perspectives for the 1990s. Cancer Res.51:5023s-5044s.
77.
Hartwell, L.H., and M.B. Kastan.1994. Cell cycle control and cancer. Science266:1821-1828.
78.
Heath, C.W. Jr.1996. Electromagnetic field exposure and cancer: A review of epidemiologic evidence. Cancer46:29-44.
79.
Hegi, M.E., D. Ulrich, P. Sagelsdorff, C. Richter, and W.K. Lutz.1990. No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet. Mutat. Res. 238:325-329.
80.
Heim, S., N. Mandahl, and F. Mitelman.1988. Genetic convergence and divergence in tumor progression. Cancer. Res. 48:5911-5916.
81.
Henson, D.E., and J. Albores-Saavedra .1986. The pathology of incipient neoplasia. Philadelphia: W. B. Saunders .
82.
Hiraoka, M., J. Miyakoshi, Y.P. Li, B. Shung, H. Takebe, and M. Abe.1992. Induction of c-fos gene expression by exposure to a static magnetic field in HeLaS3 cells. Cancer. Res. 52:6522-6524.
83.
Holmberg, B.1995. Magnetic fields and cancer: Animal and cellular evidence- an overview. Environ. Health Perspect. 103:63-67.
84.
Hunter, T.1991. Cooperation between oncogenes. Cell64:249-270.
85.
Hunter, T., and J. Pines.1994. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell79:573-582.
86.
Issemann, I., and S. Green.1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature347:645-650.
87.
Jass, J.R., S.M. Stewart, J. Stewart, and M.R. Lane.1994. Hereditary non-polyposis colorectal cancer-morphologies, genes and mutations. Mutat. Res. 310:125-133.
88.
Kadlubar, F.F.1994. Biochemical individuality and its implications for drug and carcinogen metabolism: Recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans. Drug Metab. Rev. 26:37-46.
Kakiuchi, H., T. Ushijima, M. Ochiai, K. Imai, N. Ito, A. Yachi, T. Sugimura, and M. Nagao.1993. Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: Possible alternative mechanisms of human colon carcinogenesis. Mol. Carcinog. 8:44-48.
91.
Kakunaga, T.1975. The role of cell division in the malignant transformation of mouse cells treated with 3-methylcholanthrene. Cancer Res . 35:1637-1642.
92.
Kallio, A., M. Löfman, H. Pösö, and J. Jänne.1977. Inhibition of ornithine decarboxylase by diamines in regenerating rat liver. FEBS Lett. 79:195-199.
93.
Kasai, H., Y. Okada, S. Nishimura, M.S. Rao, and J.K. Reddy.1989. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator . Cancer Res. 49:2603-2605.
94.
Kemp, C.J., C.N. Leary, and N.R. Drinkwater .1989. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc. Natl. Acad. Sci. USA86:7505-7509.
95.
Kerbacher, J.J., M.L. Meltz, and D.N. Erwin.1990. Influence of radiofrequency radiation on chromosome aberrations in CHO cells and its interaction with DNA-damaging agents. Radiat. Res. 123:311-319.
96.
Khalil, A.M., and W. Qassem.1991. Cytogenetic effects of pulsing electromagnetic fields on human lymphocytes in vitro: Chromosome aberrations, sister-chromatid exchanges and cell kinetics. Mutat. Res. 247:141-146.
97.
Klaunig, J.E.1993. Selection induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital. Environ. Health Perspect. 101:235-240.
98.
Knudson, A.G.1993. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA90:10914-10921.
99.
Konishi, N., and Y. Hiasa.1994. Renal carcinogenesis. In Carcinogenesis, eds. M. P. Waalkes and J. M. Ward, 123-159. New York: Raven Press.
100.
Kumar, R., and M. Barbacid.1988. Oncogene detection at a single cell level. Oncogene3:647-651.
101.
Laconi, E., S. Vasudevan, P.M. Rao, S. Rajalakshmi, P. Pani, and D.S.R. Sarma.1994. An earlier proliferative response of hepatocytes in y-glutamyltransferase positive foci to partial hepatectomy . Cancer Lett. 81: 229-235.
102.
Lacy-Hulbert, A., R.C. Wilkins, T.R. Hesketh, and J.C. Metcalfe.1995. No effect of 60 Hz electromagnetic fields on MYC or beta-actin expression in human leukemia cells. Radiat. Res. 144:9-17.
103.
Lane, D.P.1992. p53, guardian of the genome. Cancer358:15-16.
104.
Ledbetter, D.H.1992. Minireview: Cryptic translocations and telomere integrityAm. J. Hum. Genet. 51:451-456.
105.
Levine, A.J.1993. The tumor suppressor genes. Annu. Rev. Biochem. 62:623-651.
106.
Liao, D., I. Porsch-Hällström, J.A. Gustafsson, and A. Blanck.1993. Sex differences at the initiation stage of rat liver carcinogenesis-influence of growth hormone. Carcinogenesis14:2045-2049.
107.
Liburdy, R.P., D.E. Callahan, J. Harland, E. Dunham, T.R. Sloma, and P. Yaswen.1993. Experimental evidence for 60 Hz magnetic fields operating through the signal transduction cascade. FEBS Lett. 334:301-308.
108.
Lijinsky, W.1990. Non-genotoxic environmental carcinogens. J. Envir. Sci. Hlth. C8:45-87.
109.
Lijinsky, W., M. D. Reuber, and C. W. Riggs. 1981. Dose response studies of carcinogenesis in rats by nitrosodiethylamine. Cancer Res. 41:4997-5003. Liu, E., C. Dollbaum, G. Scott, C. Rochlitz, C. Benz, and H. S. Smith. 1988. Molecular lesions involved in the progression of a human breast cancer. Oncogene 3:323-327.
110.
Löscher, W., and M. Mevissen.1995. Linear relationship between flux density and tumor co-promoting effect of prolonged magnetic field exposure in a breast cancer model. Cancer Lett. 96:175-180.
111.
Löscher, W., M. Mevissen, W. Lehmacher, and A. Stamm.1993. Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic field. Cancer Lett . 71:75-81.
112.
Maekawa, A., and K. Mitsumori.1990. Spontaneous occurrence and chemical induction of neurogenic tumors in rats-influence of host factors and specificity of chemical structure. Crit. Rev. Toxicol. 20:287-310.
113.
Maekawa, A., T. Ogiu, C. Matsuoka, H. Onodera, K. Furuta, Y. Kurokawa, M. Takahashi, T. Kokubo, H. Tanigawa, Y. Hayashi, M. Nakadate, and A. Tanimura.1984. Carcinogenicity of low doses of N-ethyl-N-nitrosourea in F344 rats; a dose-response study Gann. 75:117-125.
114.
Magnuson, B.A., I. Carr, and R.P. Bird.1993. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res. 53:4499-4504.
115.
Mailhes, J.B., D. Young, A.A. Marino, and S.N. London.1997. Electromagnetic fields enhance chemically-induced hyperploidy in mammalian oocytes. Mutagenesis12:347-351.
116.
Majno, G., and I. Joris.1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J Pathol. 146:3-15.
Masuhara, M., H. Ogasawara, S.L. Katyal, T. Nakamura, and H. Shinozuka.1993. Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats. Carcinogenesis14:1579-1584.
119.
Mayer, E.A.1994. Signal transduction and intercellular communication . In Gut peptides: Biochemistry and physiology, eds. J. H. Walsh and G. J. Dockray, 33-73. New York: Raven Press .
120.
McCann, J., F. Dietrich, C. Rafferty, and A.O. Martin.1993. A critical review of the genotoxic potential of electric and magnetic fields. Mutat. Res. 297: 61-95.
121.
McLean, J.R.N., A. Thansandote, D. Lecuyer, and M. Goddard.1997. The effect of 60-Hz magnetic fields on co-promotion of chemically induced skin tumors on SENCAR mice: A discussion of three studies. Environ. Health Perspect. 105:94-96.
122.
Mevissen, M., A. Stamm, S. Buntenkötter, R. Zwingelberg, U. Wahnschaffe, and W. Löscher.1993. Effects of magnetic fields on mammary tumor development induced by 7,12-dimethylbenz(a)anthracene in rats. Bioelectromagnetics14:131-143.
123.
Mevissen, M., M. Kietzmann, and W. Löscher.1995. In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA. Cancer Lett. 90:207-214.
124.
Mevissen, M., A. Lerchl, M. Szamel, and W. Löscher.1996. Exposure of DMBA-treated female rats in a 50-Hz, 50 μTesla magnetic field: Effects on mammary tumor growth, melatonin levels, and T lymphocyte activation. Carcinogenesis17:903-910.
125.
Miki, Y., J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L.M. Bennett, and W. Ding.1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science266:66-71.
126.
Miller, A.B.1981. Breast cancer. Cancer47:1109-1113.
127.
Miller, M.W., M. M. Reddy, G.R. Yettewich, and G.E. Kaufman.1976. Lack of effect of extremely low frequency electric and magnetic fields on roots of vicia faba . Environ. Exp. Botany16:83-88.
128.
Miller, R.W.1978. Environmental causes of cancer in childhood. In Advances in pediatrics, Vol. 25, ed. L. A. Barness, 97-119. Chicago: Chicago Year Book Medical Publishers.
129.
Monti, M.G., L. Pernecco, M.S. Moruzzi, R. Battini, P. Zaniol, and B. Barbiroli.1991. Effect of ELF pulsed electromagnetic fields on protein kinase C activation process in HL-60 leukemia cells. J. Bioelectricity10:119-130.
130.
Moolgavkar, S.H., N.E. Day, and R.G. Stevens.1980. Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J. Natl. Cancer Inst. 65:559-569.
131.
Moore, M.A., K. Nakagawa, K. Satoh, T. Ishikawa, and K. Sato.1987. Single GST-P positive liver cells-putative initiated hepatocytes. Carcinogenesis8:483-486.
132.
Morley, S.J., and G. Thomas.1991. Intracellular messengers and the control of protein synthesis. Pharmac. Ther. 50:291-319.
133.
Motojima, K.1993. Peroxisome proliferator-activated receptor (PPAR): Structure, mechanisms of activation and diverse functions. Cell. Struct. Funct. 18:267-277.
134.
Mottram, J.C.1944. A developing factor in experimental blastogenesis . J. Pathol. Bacteriol. 56:181-187.
135.
Moulder, J.E., and K.R. Foster.1995. Biological effects of power-frequency fields as they relate to carcinogenesis. Proc. Soc. Exp. Biol. Med. 209:309-324.
136.
Müller, H.1990. Recessively inherited deficiencies predisposing to cancer . Anticancer Res. 10:513-518.
137.
Nafziger, J., H. Desjobert, B. Benamar, and J.J. Guillosson .1993. DNA mutations and 50 Hz electromagnetic fields. Bioelectrochem. Bioenerget. 30:133-141.
138.
Nelson, M.A., B.W. Futscher, T. Kinsella, J. Wymer, and G.T. Bowden.1992. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl. Acad. Sci. USA89:6398-6402.
139.
Noble, R.L.1977. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res. 37:82-94.
140.
Nowell, P.C.1990. Cytogenetics of tumor progression. Cancer65:2172-2177.
141.
Nuzum, E.O., A.M. Malkinson, and D.G. Beer.1990. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas . Mol. Carcinog. 3:287-295.
142.
Okuno, K., T. Ano, and M. Shoda.1991. Effect of super high magnetic field on the growth of Escherichia coli. Biotechnol. Lett. 13:745-750.
143.
Ottaggio, L., S. Bonatti, Z. Cavalieri, and A. Abbondandolo .1993. Chromosomes bearing amplified genes are a preferential target of chemicals inducing chromosome breakage and aneuploidy. Mutat. Res. 301:149-155.
144.
Ottani, V., M.G. Monti, G. Piccinini, L. Pernecco, P. Zaniol, A. Ruggeri, and B. Barbiroli.1984. Pulsed electromagnetic fields increase the rate of rat liver regeneration after partial hepatectomy. Proc. Soc. Exp. Biol. Med. 176:371-377.
145.
Papadopoulos, N., N.C. Nicolaides, and Y.F. Wei.1994. Mutation of a mutL homolog in hereditary colon cancer. Science263:1625-1628.
146.
Paraskeva, C., and A.C. Williams.1992. Promotability and tissue specificity of hereditary cancer genes: Do hereditary cancer patients have a reduced requirement for tumor promotion because all their somatic cells are heterozygous at the predisposing locus?Mol. Carcinog. 5:4-8.
147.
Pawson, T.1993. Signal transduction-a conserved pathway from the membrane to the nucleus. Develop. Genetics14:333-338.
148.
Pegg, A.E., and W. Perry.1981. Alkylation of nucleic acids and metabolism of small doses of dimethylnitrosamine in the rat. Cancer Res . 41:3128-3132.
149.
Pellegata, N.S., F. Sessa, B. Renault, M. Bonato, B.E. Leone, E. Solcia, and G.N. Ranzan.1994. K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumor progress through different genetic lesions . Cancer Res. 54:1556-1560.
150.
Peteiro-Cartelle, F.J., and J. Cabezas-Cerrato .1989. Absence of kinetic and cytogenetic effects on human lymphocytes exposed to static magnetic fields. J. Bioelectricity8:11-19.
151.
Peto, R., R. Gray, P. Brantom, and P. Grasso.1991. Effects on 4080 rats of chronic ingestion of N-notrosodiethylamine or N-nitrosodimethylamine: A detailed dose-response studyCancer Res. 51:6415-6451.
152.
Phillips, J.L.1993. Effects of electromagnetic field exposure on gene transcription . J. Cell Biochem. 51:381-386.
153.
Phillips, J.L., W. Haggren, W.J. Thomas, T. Ishida-Jones, and W.R. Adey.1992. Magnetic field-induced changes in specific gene transcription. Biochim. Biophys. Acta1132:140-144.
154.
Pino, A., R. Ricci, and G. Piombo.1985. Absence of DNA damage in liver, spleen and kidney of rats after exposure to therapeutic magnetic fields. IRCS Med. Sci. 13:257-258.
155.
Pitot, H.C.1986. Fundamentals of oncology, 3rd edition. New York: Marcel Dekker .
156.
Pitot, H.C.1990. Altered hepatic foci: Their role in murine hepatocarcinogenesis . Annu. Rev. Pharmacol. Toxicol. 30:465-500.
157.
Pitot, H.C.1991. Endogenous carcinogenesis: The role of tumor promotion . Proc. Soc. Exp. Biol. Med. 198:661-666.
158.
Pitot, H.C.1993a. The dynamics of carcinogenesis: Implications for human risk. CIIT Activities13:1-6.
159.
Pitot, H.C.1993b. The molecular biology of carcinogenesis. Cancer72:962-970.
160.
Pitot, H.C., and Y.P. Dragan.1994. Chemical induction of hepatic neoplasia . In The liver: Biology and pathobiology, Third Edition, eds. I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. A. Schachter , and D. A. Shafritz, 1467-1495. New York: Raven Press.
161.
Pitot, H.C., and Y.P. Dragan.1995. The instability of tumor promotion in relation to human cancer risk. Prog. Clin. Biol. Res. 391:21-38.
162.
Pitot, H.C., and Y.P. Dragan.1996. Chemical carcinogenesis. In Casarett & Doull's toxicology, 5th edition, ed. C. D. Klassen, 201-267. New York: McGraw-Hill.
163.
Pitot, H.C., T.L. Goldsworthy, S. Moran, W. Kennan, H.P. Glauert, R.R. Maronpot, and H.A. Campbell.1987. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationship to altered hepatic foci. Carcinogenesis8:1491-1499.
164.
Port, R., D. Schmähl, and J. Wahrendorf.1976. Some examples of dose-response studies in chemical carcinogenesis. Oncology33:66-71.
165.
Pretlow, T.G., M. Nagabhushan, M. Sy, Y. Guo, and T.P. Pretlow.1994. Putative preneoplastic foci in the human prostate. J. Cell Biochem. 19:224-231.
166.
Pretlow, T.P.1994. Alterations associated with early neoplasia in the colon . In Biochemical and molecular aspects of selected cancers , Vol. 2, ed. T. G. Pretlow and T. P. Pretlow, 93-141. San Diego: Academic Press.
167.
Pretlow, T.P., M.A. O'Riordan, K.M. Spancake, and T.G. Pretlow.1993. Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen. Am. J. Pathol. 142:1695-1700.
168.
Purnell, D.M.1980. The relationship of terminal duct hyperplasia to mammary carcinoma in 7,12-dimethylbenzo(α)anthracene-treated LEW/Mai rats . Am. J. Pathol.98:311-324.
169.
Quintanilla, M., K. Brown, M. Ramsden, and A. Balmain.1986. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature322:78-80.
170.
Rannug, A., T. Ekström, K.H. Mild, B. Holmberg, I. Gimenez-Conti, and T.J. Slaga.1993b. A study on skin tumour formation in mice with 50 Hz magnetic field exposure. Carcinogenesis14:573-578.
171.
Rannug, A., B. Holmberg, T. Ekström, K.H. Mild, I. Gimenez-Conti, and T.J. Slaga.1994. Intermittent 50 Hz magnetic field and skin tumour promotion in SENCAR mice. Carcinogenesis15:153-157.
172.
Rannug, A., B. Holmberg, and K.H. Mild.1993a. A rat liver foci promotion study with 50-Hz magnetic fields. Environ. Res. 62:223-229.
173.
Reddy, A.L., and P.J. Fialkow.1983. Papillomas induced by initiation-promotion differ from those induced by carcinogen alone. Nature304:69-70.
174.
Reddy, J.K., and N.D. Lalwani.1983. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. 12:1-58.
175.
Reddy, J.K., and M.S. Rao.1989. Oxidative DNA damage caused by persistent peroxisome proliferation: Its role in hepatocarcinogenesis. Mutat. Res. 214:63-68.
176.
Reiter, R.J.1993. Electromagnetic fields and melatonin production . Biomed. Pharmacother. 47:439-444.
177.
Rochev, Y.A., A.A. Narimanov, E.A. Sosunov, A.N. Kozlov, and V.V. Lednev.1990. Effects of weak magnetic field on the rate of cell proliferation in culture. Studia. Biophys. 135:93-98.
178.
Rosenthal, N.1994. Molecular medicine. Regulation of gene expression . New Engl. J. Med. 331:931-933.
179.
Ross, S.M.1990. Combined DC and ELF magnetic fields can alter cell proliferation . Bioelectromagnetics11:27-36.
180.
Rothman, K.J., C.-K. Chou, R. Morgan, Q. Balzano, A.W. Guy, D.P. Funch, S. Preston-Martin, J. Mandel, R. Steffens, and G. Carlo.1996. Assessment of cellular telephone and other radio frequency exposure for epidemiologic research. Epidemiology7:291-298.
181.
Rous, P., and J.G. Kidd.1941. Conditional neoplasms and sub-threshold neoplastic states: A study of the tar tumors of rabbits. J. Exp. Med. 73:369-390.
182.
Rumsby, P.C., N.C. Barrass, H.E. Phillimore, and J.G. Evans.1991. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Carcinogenesis12:2331-2336.
183.
Rusch, H.P., B.E. Kline, and C.A. Baumann.1941. Carcinogenesis by ultraviolet rays with reference to wavelength and energy. Arch. Pathol. 31:135-146.
184.
Russo, J., L. Tait, and I.H. Russo.1983. Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am. J Pathol. 113:50-66.
185.
Saeter, G., P.E. Schwarze, J.M. Nesland, and P.O. Seglen.1988. 2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism. Carcinogenesis9:581-587.
186.
Sagan, L.A.1992. Epidemiological and laboratory studies of power frequency electric and magnetic fields. J. Am. Med. Assoc . 268:625-629.
187.
Salford, L.G., A. Brun, B.R.R. Persson, and J. Eberhardt.1993. Experimental studies of brain tumour development during exposure to continuous and pulsed 915 MHz radiofrequency radiation. Bioelectrochem. Bioenerget. 30:313-318.
188.
Samet, J.M.1997. Epidemiologic studies of ionizing radiation and cancer: Past successes and future challenges. Environ. Health Perspect . 105:883-889.
189.
Sander, C.A., T. Yano, H.M. Clark, C. Harris, D.L. Longo, E.S. Jaffe, and M. Raffeld.1993. p53 Mutation is associated with progression in follicular lymphomas. Blood82:1994-2004.
190.
Santini, R., M. Hosni, P. Deschaux, and H. Pacheco.1988. B16 melanoma development in black mice exposed to low-level microwave radiation. Bioelectromagnetics9:105-107.
191.
Sargent, L., Y.-H. Xu, G.L. Sattler, L. Meisner, and H.C. Pitot.1989. Ploidy and karyotype of hepatocytes isolated from enzyme-altered foci in two different protocols of multistage hepatocarcinogenesis in the rat. Carcinogenesis10:387-391.
192.
Schaeffer, B.K., J. Zurlo, and D.S. Longnecker .1990. Activation of c-Ki-ras not detectable in adenomas or adenocarcinomas arising in rat pancreas. Mol. Carcinog. 3:165-170.
193.
Schulte-Hermann, R., W. Bursch, B. Kraupp-Grasl, F. Oberhammer, A. Wawner, and R. Jirtle.1993. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ. Health Perspect . 101:87-90.
194.
Schulte-Hermann, R., G. Ohde, J. Schuppler, and I. Timmermann-Trosiener .1981. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin . Cancer Res. 41:2556-2562.
195.
Schulte-Hermann, R., I. Timmermann-Trosiener, G. Barthel, and W. Bursch.1990. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50:5127-5135.
196.
Schulte-Hermann, R., I. Timmermann-Trosiener, and J. Schuppler.1983. Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res. 43:839-844.
197.
Scott, D., S.M. Galloway, R.R. Marshall, M. Ishidate, Jr. , D. Brusick, J. Ashby, and B.C. Myhr.1991. Genotoxicity under extreme culture conditions . Mutat. Res. 257:147-204.
Shigenaga, M.K., C.J. Gimeno, and B.N. Ames.1989. Urinary 8-hydroxy-2'deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. USA86:9697-9701.
200.
Shivapurkar, N., Z. Tang, A. Ferreira, S. Nasim, C. Garett, and O. Alabaster.1994. Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet. Carcinogenesis15:775-778.
201.
Short, B.G., W.H. Steinhagen, and J.A. Swenberg.1989. Promoting effects of unleaded gasoline and 2,2,4-trimethylpentane on the development of atypical cell foci and renal tubular cell tumors in rats exposed to N-ethyl-N-hydroxyethylnitrosamine. Cancer Res.49:6369-6378.
Smith, R.T.1994. Cancer and the immune system. Clin. Immunol . 41:841-850.
204.
Sohal, R.S., and W.C. Orr.1992. Relationship between antioxidants, prooxidants, and the aging process. Ann. NY Acad. Sci. 663:74-84.
205.
Solt, D., and E. Farber.1976. New principle for the analysis of chemical carcinogenesis. Nature263:701-703.
206.
Stott, W.T.1988. Chemically induced proliferation of peroxisomes: Implications for risk assessment. Regulat. Toxicol. Pharmacol . 8:125-159.
207.
Strader, C.D., T.M. Fong, M.R. Tota, D. Underwood, and R.A.F. Dixon.1994. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:101-132.
208.
Stuchly, M.A., J.R.N. McLean, R. Burnett, M. Goddard, D.W. Lecuyer, and R.E.J.F. Mitchel .1992. Modification of tumor promotion in the mouse skin by exposure to an alternating magnetic field. Cancer Lett. 65:1-7.
209.
Sumi, C., K. Yokoro, T. Kajitani, and A. Ito.1980. Synergism of diethylstilbestrol and other carcinogens in concurrent development of hepatic, mammary, and pituitary tumors in castrated male rats. J. Natl. Cancer Inst. 65:169-175.
210.
Suri, A., J. deBoer, W. Kusser, and B.W. Glickman.1996. A 3 milliTesla 60 Hz magnetic field is neither mutagenic nor co-mutagenic in the presence of menadione and MNU in a transgenic rat cell line. Mutat. Res. 372:23-31.
211.
Sutherland, R.M., J.P. Marton, J.C.F. MacDonald, and R.L. Howell.1978. Effect of weak magnetic fields on growth of cells in tissue culture. Physiol. Chem. Physics. 10:125-128.
212.
Swenberg, J.A., F.C. Richardson, J.A. Boucheron, F.H. Deal, S.A. Belinsky, M. Charbonneau, and B.G. Short.1987. High- to low-dose extrapolation: Critical determinants involved in the dose response of carcinogenic substances. Environ. Health Perspect. 76:57-63.
213.
Szmigielski, S., A. Szudzinski, A. Pietraszek, M. Bielec, M. Janiak, and J.K. Wrembel.1982. Accelerated development of spontaneous and benzopyrene-induced skin cancer in mice exposed to 2450-MHz microwave radiation. Bioelectromagnetics3:179-191.
214.
Szudzinski, A., A. Pietraszek, M. Janiak, J. Wrembel, M. Kalczak, and S. Szmigielski.1982. Acceleration of the development of benzopyrene-induced skin cancer in mice by microwave radiation. Arch. Dermatol. Res. 274:303-312.
215.
Takahashi, M., A. Nishikawa, F. Furukawa, T. Enami, T. Hasegawa, and Y. Hayashi.1994. Dose-dependent promoting effects of sodium chloride (NaCl) on rat glandular stomach carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis15:1429-1431.
216.
Talalay, P., M.J. De Long, and H.J. Prochaska.1988. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis . Proc. Natl. Acad. Sci. USA85:8261-8265.
217.
Taper, H.S.1978. The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats. Cancer42:462-467.
218.
Tatematsu, M., Y. Nagamine, and E. Farber.1983. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res. 43:5049-5058.
219.
Tennant, R.W.1993. A perspective on nonmutagenic mechanisms in carcinogenesis . Environ. Health Perspect. Suppl. 101:231-236.
220.
Tokusashi, Y., I. Fukuda, and K. Ogawa.1994. Absence of p53 mutations and various frequencies of Ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens. Mol. Carcinog. 10:45-51.
221.
Tomatis, L., and H. Bartsch.1990. The contribution of experimental studies to risk assessment of carcinogenic agents in humans. Exp. Pathol. 40:251-266.
222.
Uckun, F.M., T. Kurosaki, J. Jin, X. Jun, A. Morgan, M. Takata, J. Bolen, and R. Luben.1995. Exposure of B-lineage lymphoid cells to low energy electromagnetic fields stimulates Lyn kinase. J Biol. Chem. 270:27666-27670.
223.
Valjus, J., H. Norppa, H. Järventaus, M. Sorsa, E. Nykyri, et al. 1993. Analysis of chromosomal aberrations, sister chromatid exchanges and micronuclei among power linesmen with long-term exposure to 50-Hz electromagnetic fields. Radiat. Environ. Biophys . 32:325-336.
224.
Van Duuren, B.L., A. Sivak, C. Katz, I. Seidman, and S. Melchionne.1975. The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin . Cancer Res. 35:502-505.
225.
Verma, A.K., and R.K. Boutwell.1980. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis. Carcinogenesis1:271-276.
226.
Ward, E.J.1987. Persistent and heritable structural damage induced in heterochromatic DNA from rat liver by N-nitrosodimethylamine. Biochemistry26:1709-1717.
227.
Wattenberg, L.W.1985. Chemoprevention of cancer. Cancer Res . 45:1-8.
228.
Weinberg, W.C., and P.M. Iannaccone .1988. Clonality of preneoplastic liver lesions: Histological analysis in chimeric rats. J. Cell. Sci. 89:423-431.
229.
Welch, D.R., and S.P. Tomasovic.1985. Implications of tumor progression on clinical oncology. Clin. Expl. Metastasis3:151-188.
230.
Wigley, C.B.1983. Experimental approaches to the analysis of precancer . Cancer Surv. 2:495-515.
231.
Wild, C.P., and P. Kleihues.1996. Etioiogy of cancer in humans and animals . Exp. Toxicol. Pathol. 48:95-100.
232.
Willett, W.C., and B. MacMahon.1984. Diet and cancer-an overview. Part I and II. New Engl. J. Med. 310:633-638 and 697-701.
233.
Wright, S.C., J. Zhong, and J.W. Larrick.1994. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8:654-660.
234.
Wu, R.Y., H. Chiang, and B.J. Shao.1989. The effects of 2.54-GHz radiation on DMH-induced colon cancer in mice. Eleventh Annual Meeting Abstracts, Bioelectromagnetics Society, Tucson , Arizona, June 18-22.
235.
Wu, X., and A.J. Levine.1994. p53 and E2F-1 cooperate to mediate apoptosis . Proc. Natl. Acad. Sci. USA91:3602-3606.
236.
Wyllie, A.H.1987. Apoptosis: Cell death in tissue regulation. J Pathol. 153:313-316.
237.
Wyllie, A.H.1994. Death from inside out: An overviewPhil. Trans. R. Soc. Lond. B345:237-241.
238.
Xu, Y.-H., H.A. Campbell, G.L. Sattler, S. Hendrich, R. Maronpot, K. Sato, and H.C. Pitot.1990. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers. Cancer Res. 50:472-479.
239.
Yokota, J., and T. Sugimura.1993. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J. 7:920-925.
240.
Yokota, K., U. Singh, and H. Shinozuka.1990. Effects of a choline-deficient diet and a hypolipidemic agent on single glutathione S-transferase placental form-positive hepatocytes in rat liver. Jpn. J. Cancer Res. 81:129-134.
241.
Zhang, R., J.D. Haag, and M.N. Gould.1991. Quantitating the frequency of initiation and cH-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland. Cell Growth Different. 2:1-6.
